Archive for December, 2008
Wednesday 31 December 2008 @ 11:14 am
MONTREAL - Investors in Labopharm Inc. (TSX:DDS) held a New Year's Eve celebration after the U.S. Food and Drug Administration approved Ryzolt, its once-daily formulation of painkiller tramadol.
Wednesday 31 December 2008 @ 11:06 am
MONTREAL — Investors in Labopharm Inc. pushed its shares higher after the U.S. Food and Drug Administration approved Ryzolt, its once-daily formulation of painkiller tramadol.
Wednesday 31 December 2008 @ 11:01 am
MONTREAL - Investors in Labopharm Inc. (TSX:DDS) held a New Year's Eve celebration after the U.S. Food and Drug Administration approved Ryzolt, its once-daily formulation of painkiller tramadol.
Wednesday 31 December 2008 @ 10:44 am
Retail sales of Ranbaxy Laboratories, Cipla, Nicholas Piramal, Lupin and other drug makers have jumped by over 10 per cent in the domestic market despite the sales of generics or copycat versions of patented drugs falling in leading global markets such as the US and Europe.
Wednesday 31 December 2008 @ 10:43 am
New Brunswick-based Johnson & Johnson said it is voluntarily recalling two lots of skin patches containing the pain medicine fentanyl because of possible cuts in the reservoir containing the drug.
Wednesday 31 December 2008 @ 10:21 am
Johnson and Johnson is recalling two lots of the pain patch Duragesic, or fentanyl, because tears in the products can expose users to potentially fatal doses of the drug.
Wednesday 31 December 2008 @ 10:15 am
MONTREAL - Labopharm Inc. has won U.S. Food and Drug Administration approval of Ryzolt, the Montreal-area company's once-daily formulation of painkiller tramadol.
Wednesday 31 December 2008 @ 9:57 am
Johnson & Johnson said Wednesday its PriCara division recalled two lots of the pain patch Duragesic, or fentanyl, because of tears in the products that could expose users directly to the product's effective gel, causing an overdose.
Wednesday 31 December 2008 @ 9:55 am
MONTREAL - Labopharm Inc. has won U.S. Food and Drug Administration approval of Ryzolt, the Montreal-area company's once-daily formulation of painkiller tramadol.
Wednesday 31 December 2008 @ 7:00 am
Labopharm Inc. today announced that RYZOLT , Labopharm's once-daily formulation of the analgesic tramadol, has been approved by the U.S. Food and Drug Administration . RYZOLT is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.
Categories
Monthly Archives
By Month
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
Resources
